Luke Carroll

Luke Carroll

Auto-generated profile, based on publicly available information

Luke Carroll

Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ACAngela Maria Casaril
Angela Maria Casaril
MIMarta T. Ignasiak
Marta T. Ignasiak
CCChristine Yu-Nung Chuang
Christine Yu-Nung Chuang
BVBeatriz Vieira
Beatriz Vieira
NPNathalia B. Padilha
Nathalia B. Padilha
Michael DaviesMichael Davies
Michael Davies

1 December 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LCLuke Carroll
Luke Carroll
DPDavid I. Pattison
David I. Pattison
JDJustin B. Davies
Justin B. Davies
RARobert F. Anderson
Robert F. Anderson
CLCamilo López
Camilo López
Michael DaviesMichael Davies
Michael Davies

1 April 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LCLuke Carroll
Luke Carroll
DPDavid I. Pattison
David I. Pattison
JDJustin B. Davies
Justin B. Davies
RARobert F. Anderson
Robert F. Anderson
CLCamilo López
Camilo López
Michael DaviesMichael Davies
Michael Davies

27 December 2023 in eLife
Verified
Journal Article
Open access
ADAlexis Diaz-Vegas
Alexis Diaz-Vegas
SMSøren Madsen
Søren Madsen
KCKristen C Cooke
Kristen C Cooke
LCLuke Carroll
Luke Carroll
JKJasmine Xy Khor
Jasmine Xy Khor
JBJames G Burchfield
James G Burchfield
Insulin resistance (IR) is a complex metabolic disorder that underlies several human diseases, including type 2 diabetes and cardiovascular disease. Despite extensive research, the precise mechanisms underlying IR development remain poorly understood. Previously we showed that deficiency of coenzyme Q (CoQ) is necessary and sufficient for IR in adipocytes and skeletal muscle (Fazakerley et al., 2018). Here, we provide new insights into the mechanistic connections between cellular alterations associated with IR, including increased ceramides, CoQ deficiency, mitochondrial dysfunction, and oxidative stress. We demonstrate that elevated levels of ceramide in the mitochondria of skeletal muscle cells result in CoQ depletion and loss of mitochondrial respiratory chain components, leading to mitochondrial dysfunction and IR. Further, decreasing mitochondrial ceramide levels in vitro and in animal models (mice, C57BL/6J) (under chow and high-fat diet) increased CoQ levels and was protective against IR. CoQ supplementation also rescued ceramide-associated IR. Examination of the mitochondrial proteome from human muscle biopsies revealed a strong correlation between the respirasome system and mitochondrial ceramide as key determinants of insulin sensitivity. Our findings highlight the mitochondrial ceramide–CoQ–respiratory chain nexus as a potential foundation of an IR pathway that may also play a critical role in other conditions associated with ceramide accumulation and mitochondrial dysfunction, such as heart failure, cancer, and aging. These insights may have important clinical implications for the development of novel therapeutic strategies for the treatment of IR and related metabolic disorders.

1 February 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ESEduardo Silva
Eduardo Silva
PBPablo Barrias
Pablo Barrias
EFEduardo Fuentes-Lemus
Eduardo Fuentes-Lemus
CTCristian Tirapegui
Cristian Tirapegui
AAAlexis Aspee
Alexis Aspee
CLCamilo López
Camilo López

1 August 2017 in Redox Biology
Verified
Journal Article
Open access
LCLuke Carroll
Luke Carroll
DPDavid I. Pattison
David I. Pattison
SFShanlin Fu
Shanlin Fu
CSCarl H. Schiesser
Carl H. Schiesser
Michael DaviesMichael Davies
Michael Davies
Clare HawkinsClare Hawkins
Clare Hawkins
Myeloperoxidase produces strong oxidants during the immune response to destroy invading pathogens. However, these oxidants can also cause tissue damage, which contributes to the development of numerous inflammatory diseases. Selenium containing compounds, including selenomethionine (SeMet) and 1,4-anhydro-5-seleno-D-talitol (SeTal), react rapidly with different MPO-derived oxidants to form the respective selenoxides (SeMetO and SeTalO). This study investigates the susceptibility of these selenoxides to undergo reduction back to the parent compounds by intracellular reducing systems, including glutathione (GSH) and the glutathione reductase and thioredoxin reductase systems. GSH is shown to reduce SeMetO and SeTalO, with consequent formation of GSSG with apparent second order rate constants, k2, in the range 103-104M-1s-1. Glutathione reductase reduces both SeMetO and SeTalO at the expense of NADPH via formation of GSSG, whereas thioredoxin reductase acts only on SeMetO. The presence of SeMet and SeTal also increased the rate at which NADPH was consumed by the glutathione reductase system in the presence of N-chloramines. In contrast, the presence of SeMet and SeTal reduced the rate of NADPH consumption by the thioredoxin reductase system after addition of N-chloramines, consistent with the rapid formation of selenoxides, but only slow reduction by thioredoxin reductase. These results support a potential role of seleno compounds to act as catalytic scavengers of MPO-derived oxidants, particularly in the presence of glutathione reductase and NADPH, assuming that sufficient plasma levels of the parent selenoether can be achieved in vivo following supplementation.